10:02 AM EST - Antibe Therapeutics Inc. : announced its intention to complete a non-brokered private placement of approximately 1,818,181 units at a price of $0.55 per Unit, each Unit comprised of one Common Share of the Corporation and one-half of one Common Share purchase warrant with each whole Warrant entitling the holder to purchase an additional Common Share (at a price of $0.80 per Warrant Share for a term of 36 months following the date of issuance, for gross proceeds of up to $1,000,000. Antibe Therapeutics Inc.
shares V.ATE are trading unchanged at $0.55.
